Dali Sun

Title: Dali Sun: Innovator in Nanoplasmonic Technology

Introduction

Dali Sun is a prominent inventor based in Tempe, AZ (US). He has made significant contributions to the field of nanoplasmonic technology, particularly in the detection and monitoring of cancer through innovative assays. His work focuses on enhancing the sensitivity and specificity of tumor-derived extracellular vesicle detection.

Latest Patents

Dali Sun holds a patent titled "Nanoplasmonic quantification of tumor-derived extracellular vesicles in plasma microsamples for detection and treatment monitoring." This patent describes a rapid, ultrasensitive, and inexpensive nanoplasmon-enhanced scattering (nPES) assay that can directly quantify tumor-derived extracellular vesicles (EVs) from as little as 1 μL of plasma. The assay utilizes the binding of gold nanospheres and nanorods with EV- and tumor-derived EV-specificities to produce a local plasmon effect, enhancing detection sensitivity and specificity. This nPES approach is a non-invasive method for assessing pancreatic cancer stage and treatment response, making it easily adaptable for clinical use and for diagnosing and monitoring other conditions with disease-specific EV proteins. Dali Sun has 1 patent to his name.

Career Highlights

Throughout his career, Dali Sun has worked at notable institutions, including The Methodist Hospital and Houston Methodist. His innovative research has positioned him as a key figure in the development of advanced diagnostic techniques in oncology.

Collaborations

Dali Sun has collaborated with talented individuals such as Ye Hu and Jia Fan, contributing to the advancement of his research and the development of new technologies.

Conclusion

Dali Sun's work in nanoplasmonic technology represents a significant advancement in cancer detection and monitoring. His innovative approaches have the potential to transform clinical practices and improve patient outcomes.